Main Session
Sep
29
PQA 06 - PQA 06: Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement
3355 - Safety and Feasibility of Nimotuzumab Combined with Gemcitabine and SABR-Boosted Concurrent Radiotherapy for Muscle Invasive Bladder Cancer: Initial Results from a Phase I/II Trial
Presenter(s)
Shangbin Qin, MD - Peking University First Hospital, beijing, Beijing